It all started in 1969

CellPath can trace its roots back to 1969, with the formation of Bethlehem Instruments in Hemel Hempstead, England by our current Chairman Peter Webber.

The company grew through the 1970`s and was instrumental in introducing several Histology products that were first to market, such as RDC rapid decalcifier, a product that still forms a core part of our Histology consumables range today. During this period, Bethlehem Instruments changed its name to HistoLab, reflecting the increased focus on selling a wider range of products to UK-based Histology laboratories.

Started Newtown Manufacture in 1982

Manufacture started in Newtown, Powys in 1982, with Paul Webber, our current Joint Managing Director, joining the company and overseeing the construction of a 3,000 square foot production facility. The following year, the company moved into Cytology, offering an expanded product range that included spatulas, fixatives and slide boxes.

Philip Webber, also the current Joint Managing Director, joined the company in 1984 when a further 3,000 square foot extension was added to the Newtown premises.

In 1985, HistoLab became a 100% family-owned business and continued to operate under two brands – HistoLab and CytoLab. In 1987 the company introduced the Aylesbury Spatula an alternative to the Ayre Spatula. This sampling device improved the quality of cervical samples taken.

CellPath Ltd founded in 1990

It was in 1990 that CellPath Limited was founded when HistoLab and CytoLab were merged.

Over the next decade, the company began to manufacture of some of its best-known products - CerviBrush, CerviKit, Ortho Stains and the CytoFocus CD, to become market leaders of Cytology products in the UK.

In 1999 CellPath was sold to Medical Solutions PLC, an LSE listed company. However, in December 2002 CellPath was purchased back by its founder members the Webber Family.

Moved to our Current Premises in 2005

In November 2005 CellPath moved into their new 20,000 sq. ft headquarters on the Mochdre Enterprise Park in Newtown, Mid Wales. It was around this time that CellNass was successfully launched into the market, which has seen significant growth thereafter with a new build in 2013 doubling the original CellNass capacity to meet customer demand followed by a further expansion in August 2017. During this period, CellNass was given the highest possible score by the Human Tissue Authority when assessed for suitability of practices, premises, governance and disposal.

CellPath - Model JAM-EC-350 - 2 Modular Tissue Embedding Console - Brochure

Contact supplier